Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

The International Finance Corporation (IFC), a member of the World Bank Group, has signed an agreement with Vienna Insurance Group (VIG) to acquire approximately 10% of the shares of Carpathia Pensii, a Romanian private pension company.
Romania recorded the most significant increase in industrial electricity costs across the EU during H2 2025, according to data released by Eurostat.
Polish pharmaceutical company Zakłady Farmaceutyczne Polpharma has agreed to launch a voluntary public takeover offer (VTO) for all shares of Romanian drugmaker Biofarm, according to a regulatory filing.
Romania's Ministry of Finance has launched a public consultation for the TechUp Romania funding scheme, designed to support investments in research and development of advanced technologies with production capabilities.
Visual Fan has entered the shareholding of Solbess, a company active in electricity production.